昆虫的UDP-glycosyltransferases和外来生物的新陈代谢
1Department of Entomology, Comstock Hall, Cornell University, Ithaca, NY 14853, USA.
Pesticide biochemistry and physiology
|December 1, 2025
概括
UDP-glycosyltransferases (UGTs) 是昆虫中用于排毒外来化合物的关键酶. 本综述总结了39项研究,突出了它们在异生物代谢中的作用,并确定了未来研究的领域.
科学领域:
- 生物化学 生物化学
- 毒理学 毒理学 毒理学
- 昆虫学 昆虫学是一门学科.
背景情况:
- UDP-葡萄糖转移酶 (UGTs) 是所有生物体中发现的关键酶.
- 它们将异生菌与糖结合在一起,增加了排泄的水溶性.
- 昆虫的UGT在代谢外来化合物方面发挥着重要作用.
研究的目的:
- 审查最近关于昆虫UGT及其在异生菌排毒中的参与的研究.
- 分析了39项针对20多种昆虫和虫的研究结果.
- 识别昆虫UGT中的模式,数据缺口和未来研究方向.
主要方法:
- 对39项关于昆虫UGTs的研究的文献综述.
- 与特定的UGT相关的异生菌代谢的分析.
- 包括30多种异生物基质的数据.
主要成果:
- 已证明与昆虫和虫中的特定UGT相关的异生菌代谢.
- 在使用RNA干扰 (RNAi) 来研究UGT功能时观察到相对较小的表型.
- 确定了30多种异生菌作为昆虫UGT的潜在基质.
结论:
- 昆虫的UGT对异生生物排毒至关重要,尽管RNAi研究显示效果适度.
- 取得了显著的进展,但在了解UGT功能方面仍然存在数据差距.
- 需要进一步的研究,以充分阐明昆虫UGTs的角色和基质特异性.
更多相关视频
相关概念视频
Phase II Reactions: Glucuronidation
1.6K
Glucuronidation, a pivotal phase II biotransformation process, involves the coupling of glucuronic acid to a drug or xenobiotic. Given its widespread occurrence and critical role in drug metabolism, it's considered the most crucial phase II reaction. It enhances the water solubility of substances, aiding their expulsion from the body. The driving force behind these reactions is a group of enzymes known as UDP-glucuronosyltransferases (UGTs). UGTs facilitate the transfer of a glucuronic acid...
1.6K
Drug Metabolism: Phase II Reactions
4.8K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
4.8K
Drug Biotransformation: Overview
3.5K
Pharmaceutical substances known as xenobiotics are predominantly lipophilic and nonionized. This enables them to permeate lipid bilayers, such as cell membranes, and interact with intracellular target receptors. Lipophilic drugs have an advantage in crossing biological barriers and reaching their intended sites of action. However, lipophilic drugs often have a restricted capacity for renal expulsion or elimination from the body. When these drugs enter the kidneys and undergo glomerular...
3.5K
Drug Biotransformation: Overview
2.4K
Biotransformation, also known as drug metabolism, is a vital physiological process that chemically alters drugs, facilitating their elimination from the body and terminating their action. This process involves two main phases: phase I and phase II reactions. Phase I reactions, including oxidation, reduction, and hydrolysis, introduce or unmask polar functional groups on the drug molecule, thereby increasing its water solubility. By enhancing water solubility, the drug becomes more hydrophilic...
2.4K
Carrier-Mediated Transport
981
Carrier-mediated transport is a pivotal process in drug absorption, particularly for lipid-insoluble drugs, and encompasses facilitated diffusion and active transport. Facilitated diffusion allows drugs to move along their concentration gradient without energy expenditure, while active transport utilizes ATP to drive drug movement against this gradient.
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
Active transport involves two types of membrane-spanning transporters: uptake and efflux. Uptake transporters are expressed in the small...
981
Pharmacokinetics in Obese Patients: Drug Metabolism and Excretion
161
Drug metabolism, a critical process in the liver, involves two primary phases: Phase I reactions and Phase II conjugation. Obesity introduces significant alterations in this metabolic process, primarily due to fatty infiltration of the liver, leading to conditions such as nonalcoholic fatty liver disease (NAFLD). This condition can modify the activities of both Phase I and II enzymes, impacting how drugs are metabolized in obese patients.Phase I metabolism sees variable effects across...
161


